The Europe mammography systems market was valued at US$511.67 million in 2019 and is projected to reach US$ 874.84 million by 2027; it is expected to grow at a CAGR of 7.1%during 2020–2027.
The Europe mammography systemsmarket growth is primarily attributed to the growing prevalence of obesity in women and an upsurge in funding for breast cancer screening programs. Further, the increase in number of diagnostic centers for breast cancer screening programs is likely to fuel the mammography systems marketduring the forecast period.However, issues related to results of mammogram screening in emerging countries obstruct the growth of the market to a certain extent.
The prevalence of breast cancer is growing worldwide and has resulted in increased demand for mammography systems for diagnosis. A few of the common symptoms of breast cancer are appearance of inverted nipples, changes in breast shape, development of lumps in breast, and red or scaly patch of skin, or sore nipples. Breast cancer is one of the most common types of cancer among women, and it is likely to occur in every 1 in 21 women. Obesity is one of the leading risk factors for postmenopausal breast cancer. According to country estimates for 2008, ~50% of both men and women in the WHO European region were overweight, and ~23% females and 20% males were obese.The highest proportions of women who were said to be obese were recorded in Malta (23.9%), Latvia (23.3%), Estonia (21.5%), and the UK (20.4%).With the growing trend of sedentary lifestyle and change in work culture, obesity is becoming a predominant risk factor of various health complications. Enhanced local estrogen production and increased serum estrogen levels have been considered primary inducers of the mechanism by which the occurrence of breast cancer is promoted in postmenopausal women.The Million Women Study followed 1.2 million UK women with age 50–64 years for a mean of 5.4 years, including 45,037 with breast cancer; Its results indicate ~30% greater risk of developing postmenopausal breast cancer with increase in obesity.
Breast cancer awareness is causing many countries to perform trials and come up with asolution to reduce the causal factors. The Italian Diet and Androgens?5 (DIANA?5) trial accrued 1208 survivors of breast cancer during 2008–2010 to test the effects of an intensive group diet and exercise intervention, over 5 years. Such weight loss intervention trials would help eliminate the risk of breast cancer in women. Further, with the increased awareness regarding breast cancer, more women are adopting for breast cancer screenings, which is adding to the demand for mammography systems in Europe.
Europe has been enormously hit by the COVID-19 outbreak affecting many of its countries on a large scale. Germany, Spain, Italy, UK, and France, along with other European countries, are continually witnessing a rise in several coronavirus cases every day. Europe is facing a massive impact on an outbreak due to the exponential growth of infections in the region. The breast imaging industry is immensely affected by impact of the COVID-19 pandemic. Also, some of the countries have almost stopped breast screening & diagnostics, while other hospitals around the globe are prioritizing treatments for the patient who require urgent immediate care. Social distancing measures are implemented, leading to reduction in workforce in mammography settings which are impacting on the screening tests. Such conditions are generating obstacles in demand for breast imaging which are expected to have negative impact on the market growth.
Based on product,the Europe mammography systems market is segmented into full field digital mammography systems, breast tomosynthesis systems, and analog systems.Thefull field digital mammography systemssegment accounted for the largest share in the market in 2019. However, the breast tomosynthesis systems segment is anticipated to register the highest CAGR in the market during 2020–2027.
Based on technology, theEurope mammography systems market, by technology, is segmented into screen film, 2D mammography, 3D mammography, and others. The 2D mammography technology held the largest share of the market in 2019. However, the 3D mammography segment is estimated to register the highest CAGR in the market during the forecast period.
Based on enduser, the Europemammography systems market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment held the largest share of the market in 2019; and the market for the same is projected to grow at the highest CAGR during 2020–2027.
A few of the major primary and secondary sources referred to while preparing this report on the Europe mammography systems market are Cancer Research UK, The Million Women Study (UK) , and European Breast Cancer Screening Network.